Xencor (XNCR) Other Non-Current Assets (2013 - 2026)
Xencor (XNCR) reported Other Non-Current Assets of $191000.0 for Q1 2026, down 61.65% year-over-year from $498000.0 in Q1 2025, and down 61.65% quarter-over-quarter from $498000.0 in Q4 2025.
Xencor (XNCR) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Other Non-Current Assets data on file, last reported at $191000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $191000.0, down 61.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $191000.0 (down 61.65% YoY), and the FY2025 annual result was $498000.0, changed 0.0% from the prior year.
- Other Non-Current Assets fell to $191000.0 in Q1 2026 per XNCR's latest filing, from $498000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $648000.0 in Q4 2023 and troughed at $191000.0 in Q1 2026.
- A 5-year average of $449500.0 and a median of $449000.0 in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets tumbled 98.17% in 2022, then rose 24.5% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $613000.0 in 2022, then advanced by 5.71% to $648000.0 in 2023, then decreased by 23.15% to $498000.0 in 2024, then changed by 0.0% to $498000.0 in 2025, then slumped by 61.65% to $191000.0 in 2026.
- Business Quant data shows XNCR's Other Non-Current Assets at $191000.0 in Q1 2026, $498000.0 in Q4 2025, and $288000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 191,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 191,000.00 |
| Dec 31, 2025 | 498,000.00 |
| Sep 30, 2025 | 288,000.00 |
| Jun 30, 2025 | 286,000.00 |
| Mar 31, 2025 | 498,000.00 |
| Dec 31, 2024 | 498,000.00 |
| Sep 30, 2024 | 385,000.00 |
| Jun 30, 2024 | 384,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 378,000.00 |
| Sep 30, 2022 | 613,000.00 |
| Jun 30, 2022 | 613,000.00 |
| Mar 31, 2022 | 613,000.00 |
| Dec 31, 2021 | 653,000.00 |
| Sep 30, 2021 | 33.46 Mn |
| Jun 30, 2021 | 4.35 Mn |
| Mar 31, 2021 | 10.42 Mn |
| Dec 31, 2020 | 212,000.00 |
| Sep 30, 2020 | 8.61 Mn |